Wellington Management Group
CNTA

Wellington Management Group’s Centessa Pharmaceuticals CNTA Stock Holding History

Wellington Management Group’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-50,180
Closed -$1.26M – 1897
2025
Q4 		$1.26M Sell
50,180
-32,485
-39% -$823K ﹤0.01% 1679
2025
Q3 		$2M Sell
82,665
-66,786
-45% -$1.19M ﹤0.01% 1629
2025
Q2 		$1.96M Buy
149,451
+10,684
+8% +$135K ﹤0.01% 1586
2025
Q1 		$2M Buy
138,767
+23,660
+21% +$387K ﹤0.01% 1560
2024
Q4 		$1.93M Buy
115,107
+14,494
+14% +$240K ﹤0.01% 1572
2024
Q3 		$1.61M Buy
+100,613
New +$1.23M ﹤0.01% 1604
2022
Q2 		– Sell
-727,273
Closed -$6.52M – 2089
2022
Q1 		$6.52M Hold
727,273
– – ﹤0.01% 1317
2021
Q4 		$8.19M Buy
+727,273
New +$9.79M ﹤0.01% 1312
2021
Q3 		– Sell
-1,106,577
Closed -$24.6M – 2164
2021
Q2 		$24.6M Buy
+1,106,577
New +$26M ﹤0.01% 1041

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wellington Management Group's CNTA Position: Q1 2026 in Review

Wellington Management Group sold out of Centessa Pharmaceuticals (CNTA) in Q1 2026, closing a stake of 50,180 shares — an estimated $1.26M sold.

Wellington Management Group first reported a position in CNTA in Q2 2021 and held it in 9 quarters. The position peaked at $24.6M in Q2 2021. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Wellington Management Group reported no remaining Centessa Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Wellington Management Group sold 50,180 Centessa Pharmaceuticals shares in Q1 2026, an estimated $1.26M.
  • Wellington Management Group first reported a position in Centessa Pharmaceuticals in Q2 2021 and held it in 9 quarters.
  • Wellington Management Group's Centessa Pharmaceuticals position peaked at $24.6M in Q2 2021.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.